BeatPark: Self-rehabilitation in Walking With Parkinson's Disease
Launched by CLINIQUE BEAU SOLEIL · Sep 8, 2020
Trial Information
Current as of May 24, 2025
Recruiting
Keywords
ClinConnect Summary
The BeatPark trial is studying how music can help improve walking in people with Parkinson's disease (PD). Researchers believe that music can make walking easier by matching its rhythm to the way a person walks. The BeatPark app uses special insoles to detect a participant's walking pace and then adjusts the music tempo to support their movements. The goal is to see if listening to this synchronized music, compared to random music or no music at all, can help participants walk better and more comfortably.
To be eligible for this study, participants must be between 35 and 95 years old, have a confirmed diagnosis of Parkinson's disease, and be able to walk for 30 minutes without assistance. They should also be receiving consistent medication for their condition. Participants will be asked to use the BeatPark app during their rehabilitation sessions and will be monitored to see how the music affects their walking. This trial is currently seeking volunteers and aims to help improve the daily lives of those with walking difficulties due to Parkinson's disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Specific Inclusion Criteria:
- • Have a diagnosis of idiopathic PD according to the MDS clinical Diagnostic Criteria for PD (Postuma et al. 2015);
- • Have a walking disorder defined by the neurologist (Item 10 of the MDSUPDRS-III ≥1);
- • Be able to walk 30 consecutive minutes without technical assistance (e.g. cane or walker) or human assistance;
- • Receive an uninterrupted antiparkinsonian pharmacological treatment since one month (and throughout the study period).
- Non-Specific Inclusion Criteria:
- • Be over 35 and under 95 of age;
- • Be able to understand the nature, purpose and methodology of the study and agree to cooperate during assessments;
- • Have signed the informed consent;
- • Be affiliated to a social security plan or affiliated to such a equivalent health plan.
- Non-Inclusions:
- Specific Non-Inclusion Criteria:
- • Presence of signs in favor of an atypical parkinsonian syndrome (involvement oculomotor, early falls, hallucinations, Montreal Cognitive Assessment \<21/30, severe and early dysautonomia);
- • Have a hearing impairment;
- • Have any other neurological damage that affects walking;
- • Have a walking disorder of other origin (e.g. orthopedic, rheumatological, etc.);
- • Have severe or unbalanced heart or respiratory Failure which contraindicates walk rehabilitation.
- Non-Specific Non-Inclusion Criteria:
- • Adult under legal protection or unfit to express their consent (Article 1121-8 of the CSP);
- • Vulnerable people (Article L 1121-6 of the CSP);
- • Loss of liberty by judicial or administrative decision;
- • High probability of non-compliance with the protocol or abandonment during the study;
- • Pregnant / lactating women.
- Non-Inclusion Criteria for the subgroup that will carry out the MRI ancillary study:
- • Pacemaker or neurosensory stimulator or implantable defibrillator;
- • Cochlear implants;
- • Foreign ferromagnetic ocular or cerebral bodies close to nervous structures
- • Metal prosthesis;
- • Agitation of the participants: non-cooperative or agitated participants;
- • Claustrophobic participants;
- • Pregnant woman;
- • Ventriculo-peritoneal neurosurgical bypass valves;
- • Braces.
- Exclusion Criteria:
- • Participant no longer wishing to participate in the study, or during the study with refusal to use data until the time of the study exit;
- • A change in the background treatment of PD will not systematically justify leaving the study but will be evaluated by the scientific committee on a case-by-case basis.
About Clinique Beau Soleil
Clinique Beau Soleil is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies. With a strong focus on dermatology and aesthetic medicine, Clinique Beau Soleil collaborates with healthcare professionals and research institutions to conduct rigorous clinical trials that adhere to the highest ethical standards and regulatory guidelines. Committed to patient safety and scientific integrity, the organization leverages cutting-edge methodologies and a patient-centric approach to develop new therapies and enhance existing treatments, ultimately contributing to the evolution of healthcare in the field of skin health and aesthetics.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, Hérault, France
Patients applied
Trial Officials
Valérie Cohen, M.D.
Principal Investigator
Clinique Beau Soleil
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials